期刊文献+

沉默过氧化物酶体增殖子活化受体γ表达降钙素基因相关肽基因重组载体的构建与鉴定 被引量:5

Construction and identification of the recombinant vector silencing peroxisome proliferator-activated receptor-γand expressing calcitonin gene-related peptide gene
原文传递
导出
摘要 目的 构建与鉴定沉默过氧化物酶体增殖子活化受体γ(PPARγ)同时表达降钙素基因相关肽(CGRP)基因重组载体.方法 选用pGFP-V-RS载体,将PPARγ小干扰RNA(siRNA)寡核苷酸靶序列连接入pGFP-V-RS载体,酶切鉴定及测序正确后得到重组载体pGFP-V-RS-siPPARγ;将CGRP片段与Mlu Ⅰ酶切,并与末端羟基化的线性质粒pGFP-V-RS重组连接,得到重组载体pGFP-V-RS-exCGRP.将获取的CGRP基因片段连接入线性化重组载体pGFP-V-RS-siPPARγ,酶切鉴定及测序正确后得到重组载体pGFP-V-RS-siPPARγ-exCGRP.收集第3代HEK-293细胞,将细胞分为4组:CON组:转染空载体pGFP-V-RS质粒,作为对照;SI组:转染重组载体pGFP-V-RS-siPPARγ质粒;EX组:转染重组pGFP-V-RS-exCGRP质粒;DOU组:转染重组双基因载体pGFP-V-RS-siPPARγ-exCGRP质粒.每组电极杯中加入5x106个细胞,并分别加入上述质粒2.5μl,给予直流电低压脉冲1次,时间15 ms.培养48 h后收集各组细胞,用逆转录-聚合酶链反应(RT-PCR)与Western blot检测细胞内PPAR、CGRP mRNA及蛋白的表达.结果 重组双基因载体pGFP-V-RS-siPPARγ-exCGRP经酶切鉴定及测序结果与设计完全一致.电转染HEK-293细胞后,DOU组细胞PPARγ基因呈低表达,PPARγmRNA与其蛋白的相对表达量为0.036±0.003、0.108 ±0.031,与EX组(0.156±0.014、0.778±0.103)及CON组(0.148±0.014、0.742 ±0.143)比较,差异有统计学意义(P<0.05),与SI组(0.054±0.005、0.135 ±0.039)比较,差异无统计学意义(P>0.05).DOU组细胞CGRP基因呈高表达,CGRP mRNA与其蛋白的相对表达量为1.144±0.106、1.244±0.184,与SI组(0.320±0.030、0.370±0.089)及CON组(0.444 ±0.041、0.274±0.062)比较,差异有统计学意义(P<0.05),与EX组(1.021 ±0.095、1.221±0.181)比较,差异无统计学意义(P>0.05).结论 成功构建出沉默PPARγ基因并表达CGRP基因的重组载体pGFP-V-RS-siPPARγ-exCGRP,能够有效阻断PPARγ基因表达,同时促进CGRP基因表达. Objective To construct the recombinant vector silencing peroxisome proliferator-activated receptor-γ (PPARγ) and expressing calcitonin gene-related peptide (CGRP) gene.Methods The pGFP-V-RS vector we selected contains a small interfering RNA (siRNA) expressing unit,and also can express exogenous gene inserted.The PPARγ siRNA oligonucleotides sequence was ligated into pGFP-VRS vector after annealling,and then PPAR siRNA recombinant vector (pGFP-V-RS-siPPARγ) was obtained by restriction analysis and DNA sequencing.The CGRP gene fragment was ligated into linear plasmids pGFP-V-RS-siPPARγrecombinant vector,and then the recombinant vector pGFP-V-RS-siPPARγ-exCGRP was obtained by restriction analysis and DNA sequencing.The HEK-293 cells were collected and divided into 4 groups at random.In control group,the cells were only transfected with vector pGFP-V-RS plasmid.In SI group,the cells were transfected with recombinant vector pGFP-V-RS-siPPARγplasmid.In EX group,the cells were transfected with recombinant vector pGFP-V-RS-exCGRP plasmid.In DOU group,the cells were transfected with pGFP-V-RS-siPPARγ-exCGRP plasmid.There were 5 × 106 HEK-293 cells in electrode cup of each group,and 2.5 μl above-mentioned plasmids were added respectively.The cells were given DC voltage pulse one time (15 ms).The cells were harvested in each group after culture for 48 h,and CGRP and PPARγmRNA and protein expression levels were detected by using reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting.Results The results of restriction analysis and DNA sequencing were completely matched with those of the designed sequences after the PPARγsiRNA oligonucleotides sequence and CGRP gene fragment were cloned into pGFP-V-RS vector.After recombinant vector pGFP-V-RS-siPPARγ-exCGRP was transfected into HEK-293 cells,the expression levels of PPARγ mRNA and protein were reduced in DOU group DOU (0.036 ±0.003 and 0.108 ±0.031)as compared with EX group (0.156 ±0.014 and 0.778 ±0.103) and control group (0.148 ±0.014 and 0.742 ± 0.143) (P 〈 0.05),but showed no significant difference in comparison to SI group (0.054 ± 0.005and 0.135±0.039) (P〉0.05).The expression level of CGRP mRNA and protein was significantly increased in DOU group (1.144 ±0.106 and 1.244 ±0.184) as compared with IS group (0.320 ±0.030 and 0.370 ±0.089) and control group (0.444 ±0.041 and 0.274 ±0.062) (P 〈0.05),but there was no significant difference in comparison to EX group (1.021 ±0.095 and 1.221 ±0.181) (P 〉0.05).Conclusion We successfully constructed the recombinant vector pGFP-V-RS-siPPARγ-exCGRP that silencing PPARγand expressing CGRP gene,and the recombinant vector can efficaciously suppress PPARγgene expression and promote CGRP gene expression simultaneously.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第1期142-145,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(81171776)
关键词 RNA干扰 过氧化物酶体增殖子活化受体-γ 降钙素基因相关肽 重组载体 RNA interference Peroxisome proliferator-activated receptor-γ Calcitonin gene- related peptide Recombinant vector
  • 相关文献

参考文献4

二级参考文献26

  • 1王玉堂,王义生,毛克亚,李月白,许振华.酒精性股骨头坏死动物模型的制作和观察[J].中华实验外科杂志,1998,15(2):182-183. 被引量:30
  • 2齐振熙,喻灿明.酒精性股骨头缺血坏死的动物模型研究[J].福建中医学院学报,2005,15(2):35-36. 被引量:14
  • 3李月白,曹亚伟,吴学建,王义生.地塞米松对人骨髓间充质干细胞成脂分化的基因调控[J].中华实验外科杂志,2006,23(12):1522-1523. 被引量:29
  • 4王义生.股骨头坏死的分期治疗[J].郑州大学学报:医学版,2009,44(2):252-256.
  • 5Matsui M, Saito S, Ohzono K, et al. Experimental steroid-induced osteonecrosis in adult rabbit with hypersensitive vasculitis. Clin Orthop, 1992,227:61.
  • 6Cui Q, Wang Y, Saleh K J, et al. Alcohol-Induced Adipogenesis in a cloned bone-marrow stem cell. J Bone Joint Surg Am,2006,88 (suppl 3 ) : 148-154.
  • 7Matsuo K, Hirohata T, Sugioka Y, et al. Influence of alcohol intake, cigarette smoking,and occupation status on idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res, 1988,234 : 115-123.
  • 8Harmon GJ. RNA interference. Nature,2002,418:244-251.
  • 9Kha HT,Basseri B,Shouhed D,Richardson J,Tetradis S,Hahn TJ,et al.Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat[].Journal of Bone and Mineral Research.2004
  • 10Mankin HJ.Nontraumatic necrosis of bone (osteonecrosis)[].The New England Journal of Medicine.1992

共引文献82

同被引文献17

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部